Clinical Trials Directory

Trials / Completed

CompletedNCT03626324

Connected Catheter (C2P) Study for Bladder Management

Clinical Evaluation of Connected Catheter 2P (C2P) Wireless Urinary Prosthesis for Management of Neurogenic Lower Urinary Tract Dysfunction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Spinal Singularity · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the safety and essential performance of the C2P System in males with neurogenic lower urinary tract dysfunction (NLUTD), both in an acute clinical setting and an extended period of home use.

Detailed description

Spinal Singularity had developed C2P system to address several drawbacks of current standard-of-care urinary catheters. The C2P is fully internal, urethral indwelling urinary prosthesis designed for improved bladder management in males with urinary retention disorders requiring catheterization, including NLUTD. The C2P is a sterile, single-extended use device that resides fully internally to the male lower urinary tract for an intended service life of up to 29 days per catheter

Conditions

Interventions

TypeNameDescription
DEVICEC2PThe C2P is a fully internal, urethral indwelling urinary prosthesis designed for improved bladder management in males with urinary retention disorders requiring catheterization, including neurogenic lower urinary tract dysfunction (NLUTD - e.g. due to spinal cord injury). The C2P is a sterile, single-extended-use device that resides fully internally to the male lower urinary tract (urethra + bladder neck) for an intended service life of up to 29 days per Catheter.

Timeline

Start date
2018-07-25
Primary completion
2019-01-31
Completion
2019-01-31
First posted
2018-08-13
Last updated
2019-02-08

Locations

8 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03626324. Inclusion in this directory is not an endorsement.